ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,845Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 2888

$668K Total Retail Price of All Prescriptions

Rank: 515 out of 2888

515 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 515 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 15,806 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,372 1,270 1 2
LISINOPRIL 754 694 2 3
AMLODIPINE BESYLATE 734 697 3 5
FUROSEMIDE 730 712 4 6
LEVOTHYROXINE SODIUM 680 662 5 1
METFORMIN HCL 576 530 6 8
METOPROLOL SUCCINATE 520 484 7 11
CLONIDINE HCL 518 482 8 39
ALENDRONATE SODIUM 494 472 9 23
METOPROLOL TARTRATE 449 432 10 10
POTASSIUM CHLORIDE 446 430 11 14
HYDROCODONE-ACETAMINOPHEN 443 402 S3 12 4
CARVEDILOL 422 410 13 21
LOSARTAN POTASSIUM 392 372 14 18
OMEPRAZOLE 381 361 15 7
ENALAPRIL MALEATE 353 334 16 49
CLOPIDOGREL 313 306 17 30
HYDROCHLOROTHIAZIDE 301 273 18 15
ALLOPURINOL 224 220 19 37
PLAVIX 214 211 20 40
GABAPENTIN 212 190 21 13
TAMSULOSIN HCL 209 208 22 29
FLUTICASONE PROPIONATE 198 171 23 32
GLIPIZIDE 195 182 24 50
ACTOS 168 145 25 108
OXAPROZIN 146 130 10 26 423
ISOSORBIDE MONONITRATE ER 145 145 27 51
DOXAZOSIN MESYLATE 145 143 27 94
GLYBURIDE 145 136 R 27 58
OXYBUTYNIN CHLORIDE ER 134 134 30 132
JANUVIA 127 123 31 48
WARFARIN SODIUM 126 126 32 22
GEMFIBROZIL 126 121 32 98
AZITHROMYCIN 122 106 34 38
TRAMADOL HCL-ACETAMINOPHEN 119 99 35 95
GLIPIZIDE ER 113 95 36 107
DONEPEZIL HCL 109 109 37 26
KLOR-CON 8 98 85 38 265
NIFEDIAC CC 95 95 39 300
KLOR-CON M20 76 74 40 90
VERAPAMIL ER 75 74 41 104
DIGOXIN 74 74 42 55
CAPTOPRIL 73 61 43 225
CIPROFLOXACIN HCL 71 69 44 47
PIOGLITAZONE HCL 68 64 R 45 248
TRAMADOL HCL 65 61 46 16
PAROXETINE HCL 65 64 46 84
GLIMEPIRIDE 59 48 48 36
SERTRALINE HCL 58 49 49 27
PROAIR HFA 58 58 49 71
AMOXICILLIN 58 48 49 117
DIOVAN 56 56 52 35
HYDRALAZINE HCL 55 53 53 59
NEXIUM 54 53 54 19
SULINDAC 54 54 54 404
PREDNISONE 53 45 56 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 49 57 28
IBUPROFEN 52 42 57 87
ATENOLOL 51 46 59 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.